Resources

CDPH Checklist Library

The California Department of Public Health (CDPH) has developed checklists and information sheets to assist hospitals and other licensed providers in understanding and preparing for relicensing surveys, as well as making changes to their licenses, bed capacities, or services. To ensure California hospitals have convenient access, CHA is making these resources available on its website.

Managed Care Organization Tax

On Nov. 5, California voters overwhelmingly approved Proposition (Prop) 35, making an existing tax on managed care organizations (MCO) permanent under state law — and directing most of the revenues toward expanding access to care for Medi-Cal patients through improved provider reimbursement. Now, work by the state, hospitals, and others to determine how these funds […]

Thank You To Our CHPAC 2024 Donors

Diane Abbett, California Healthcare Insurance Company, Inc. T Abraham, Hospital Council – Northern & Central California Amy Adome, MD, MPH, Sharp HealthCare Steve Aleman, Prime Healthcare Services Dimitrios Alexiou, FACHE, Hospital Association of San Diego & Imperial Counties Mark Allen, Marian Regional Medical Center Jared Amerson, Providence Saint John’s Health Center Sue Andersen, Marian Regional […]

Hospital Fee Program 9 (2024)

With each Hospital Fee Program renewal, DHCS retrieves the requisite hospital data and updates the fee and payment model as directed under the authorizing legislation found under state law (specifically, the Medi-Cal Hospital Reimbursement Improvement Act of 2013 codified at Welfare and Institutions Code sections 14169.50 through 14169.76).

Baxter Announces Expiration Dating Extensions for Certain Products Related to IV Solutions Disruption

As part of its efforts to mitigate the disruption to the supply of IV solutions after Hurricane Helene temporarily closed its North Cove, N.C., manufacturing plant, Baxter today said that it is now authorized by the Food and Drug Administration (FDA) to extend the use date of some products to provide a 24-month expiration from the manufacture date without relabeling the products. In a letter to customers today, Baxter said the extended expiration date is based on Baxter’s submission to the FDA including container closure integrity data, container functional performance data, and an analysis of product weight loss profiles for those certain product codes.